Home Webtool Download Documentation Contact

Targets of perturbagens

Perturbagen ID : CID51374

Perturbagen : (s)-4-({3-[2-(dimethylamino)ethyl]-1h-indol-5-yl}methyl)-1,3-oxazolidin-2-one; 311c90; 4-[[3-(2-dimethylaminoethyl)-1h-indol-5-yl]methyl]oxazolidin-2-one; Ag-zolmitriptan odt; Apo-zolmitriptan; Apo-zolmitriptan rapid; Ccp-zolmitriptan; Dom-zolmitriptan; Dom-zolmitriptan odt; Ipg-zolmitriptan; Jamp-zolmitriptan; Jamp-zolmitriptan odt; Mar-zolmitriptan; Mint-zolmitriptan; Mint-zolmitriptan odt; Mylan-zolmitriptan; Mylan-zolmitriptan odt; Nat-zolmitriptan; Pms-zolmitriptan; Pms-zolmitriptan odt; Ratio-zolmitriptan ir; Ratio-zolmitriptan odt; Riva-zolmitriptan; Sandoz zolmitriptan; Sandoz zolmitriptan odt; Septa-zolmitriptan-odt; Teva-zolmitriptan; Teva-zolmitriptan od; Van-zolmitriptan; Van-zolmitriptan odt; Zolmiptriptan; Zolmitriptan; Zolmitriptan od; Zolmitriptan odt; Zolmitriptan orally disintegrating; Zolmitriptan-odt; Zolmitriptanum; Zomig; Zomig nasal spray; Zomig rapimelt; Zomig zmt

Target	Effect	Reference
CYP1A2	-1	STITCH
HTR1A	1	DrugBank; CLUE; STITCH
HTR1B	1	DrugBank; CLUE; STITCH
HTR1D	1	DrugBank; CLUE
HTR1E	1	CLUE; STITCH
HTR1F	1	DrugBank; CLUE; STITCH